This is typically a longer-term treatment commitment
What lifestyle changes should I adopt while using semaglutide
The science of slowed gastrointestinal motility GLP-1 receptor agonists act on the gutbrain axis and are known to slow gastric emptying and overall gastrointestinal transit , contributing to early satiety and appetite suppression. As intestinal transit slows, the colon has more time to absorb water from stool , leading to hard, dry stools that are difficult to pass . Constipation is a common, dose-related adverse effect listed in FDA prescribing information for both Wegovy (semaglutide) and Zepbound (tirzepatide) and is most frequently reported during dose escalation , with improvement over time., Step-by-Step MD Protocol for Relief 1
Include foods high in fiber, but don't let them take over your plate
However, both medications require dose escalation and time to reach full therapeutic benefit
Historical and Cultural Background Historically, there are populations such as the Inuit, the Maasai, and the Chukotka who have thrived on predominantly animal-based diets due to geographic and environmental constraints that limit plant growth